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Abstract
The potential role of wild birds as carriers of highly pathogenic avian influenza virus (HPAIV) subtype H5N1 is still a matter of
debate. Consecutive or simultaneous infections with different subtypes of influenza viruses of low pathogenicity (LPAIV) are
very common in wild duck populations. To better understand the epidemiology and pathogenesis of HPAIV H5N1 infections
in natural ecosystems, we investigated the influence of prior infection of mallards with homo- (H5N2) and heterosubtypic
(H4N6) LPAIV on exposure to HPAIV H5N1. In mallards with homosubtypic immunity induced by LPAIV infection, clinical
disease was absent and shedding of HPAIV from respiratory and intestinal tracts was grossly reduced compared to the
heterosubtypic and control groups (mean GEC/100 ml at 3 dpi: 3.0610
2 vs. 2.3610
4 vs. 8.7610
4;p ,0.05). Heterosubtypic
immunity induced by an H4N6 infection mediated a similar but less pronounced effect. We conclude that the epidemiology
of HPAIV H5N1 in mallards and probably other aquatic wild bird species is massively influenced by interfering immunity
induced by prior homo- and heterosubtypic LPAIV infections.
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Introduction
Migratory birds and members of the Anseriformes order in
particular, have been suspected as carriers of highly pathogenic
avian influenza virus (HPAIV) subtype H5N1 from Southeast Asia
into central Asia, Europe and Africa. The primary occurrence of
the infection in wild birds in several countries and rapid westward
spread of HPAIV H5N1 in 2005 and 2006 have sparked such
assumptions [1]. However, the role of wild birds as culprits of
H5N1 spread has been heavily debated. Instead, legal and illegal
trading practices of poultry, poultry products and captive wild
birds were put into focus [2,3,4].
Previous experimental studies with HPAIV H5N1 strains of
different origins in various species of water birds including swans
and geese [5,6,7], gulls [8,9,10] and ducks [9,11,12] showed that
AIV seronegative swans, especially black swans (Cygnus atratus),
Canada geese (Branta canadensis) and laughing gulls (Larus atriculla)
are highly vulnerable to H5N1 infection. Diving ducks including
wood ducks (Aix sponsa) and pochards (Aythya ferina) were also found
susceptible, while dabbling ducks including northern pintails (Anas
acuta), blue-wing teals (Anas crecca), redheads (Aythya americana) and
mallards (Anas platyrhynchos) were less susceptible or tolerant [9]. In
these studies the potential role of the latter species which include
the most prevalent Eurasian wild duck species, the mallard, for
long-distance spread of H5N1 virus was stressed [11,12].
However, there is only a single report of healthy wild duck
(common pochard in Switzerland) found in Europe to be naturally
infected by HPAIV H5N1 although several clustered outbreaks of
symptomatic influenza among wild birds in Europe, some
involving mallards, have occurred [13,14]. Sample sizes in cross-
sectional surveys of wild birds may not have been large enough to
exclude a prevalence of approximately less than 1% of HPAIV
H5N1. Outbreaks among wild birds, nevertheless, proved to be
limited in temporal and geographical extension as well as in
numbers of individual birds infected. In Germany, in 2006 only
344 wild birds, mainly swans and geese, were found dying of an
HPAIV H5N1 infection despite presence of several hundred
thousand individuals of these species in the same area [13]. The
reasons for this observation are still not clear, but it is likely that
not all infected individual birds develop symptomatic influenza.
It has been hypothesized that a considerable number of these
birds may have at least partially been protected by immunity
induced by naturally occurring homosubtypic (HA homologous)
infection with avian influenza viruses of low pathogenicity
(LPAIV), and that cross reactive interference of even hetero-
subtypic (HA heterologous) LPAIV-induced immunity might have
played a silencing role. LPAIV H5 strains are being continuously
isolated from Anatidae species including mallards. AIV prevalence
in wild ducks along the southern coasts of the North and the Baltic
Seas can reach 14% during autumn migration [15]. However, no
reliable seroprevalence data from wild Anatidae exist to support this
assumption.
We tested the effect of LPAIV-induced immunity by experi-
mental inoculation of seronegative (for whole period before
PLoS ONE | www.plosone.org 1 August 2009 | Volume 4 | Issue 8 | e6706inoculation) captive mallards, with two different LPAIV subtypes,
H5N2 and H4N6, and subsequent challenge infection with
HPAIV H5N1. An H4 subtype virus was chosen because (i) the
HA of this subtype is distantly related, by genetic and antigenic
means, to that of the H5 subtype and (ii) subtype H4 viruses show
a high prevalence in wild duck populations. Mallards represent the
most abundant duck species in Eurasia and migrate over long
distances, e.g., along the East-Atlantic flyway [16]. In our study,
we provide evidence that both LPAIV-induced homo-subtypic and
heterosubtypic (H4) immunity modulate, to a different extent,
H5N1 excretion in mallards.
Materials and Methods
Viruses
The three AIV strains used in this study are maintained in the
virus repository of the OIE and National Reference Laboratory for
Avian Influenza (NRL AI) at the Friedrich-Loeffler-Institut (FLI).
The LPAIV strains A/mallard/Fo ¨hr (Germany)/Wv1806-09K/
03(H4N6) and A/duck/Potsdam/1402/86(H5N2) were used for
pre-exposure inoculation of ducks. The HPAIV strain A/duck/
Vietnam/TG24-01/05(H5N1) was used for challenge infection.
This clade 1 isolate bears a PQRERRKKR/GLF motif at the
HA0 cleavage site, and has an intravenous pathogenicity index
(IVPI) of 2.9 in specific pathogen free (SPF) chickens; in addition,
it has been found to induce clinically overt and lethal neurological
disease in adult Pekin ducks (Harder et al., unpublished).
Experimental design
Thirty–two mallards (Anas platyrhynchos) were captive-bred and
housed indoors in the quarantine building of the FLI. The birds
were handled and cared for in accordance with the Animal
Protection guidelines and legal approval (trial approval LVL M-
V/TSD/7221.3-1.1-003/07). All experiments with HPAIV were
conducted under Biosafety Level 3–agriculture (BSL-3-Ag)
conditions. At 12 weeks of age, 24 ducks were transported to
Biosafety Level 3 (BSL-3) facilities at the FLI. The ducks were
inoculated with LPAI viruses, after one week of acclimatization,
when they were 13 weeks of age. At this age juvenile free-ranging
mallards reveal highest prevalence of LPAIV infections, which is
consistent with pre-migration staging in the late summer or early
fall [9,17]. Prior to inoculation, oropharyngeal and cloacal swabs
were collected from each bird to ensure they were not infected
with any subtype of avian influenza virus at the start of the study.
In addition, serum samples had been collected regularly since
week 4 of age to confirm they were continuously AIV-negative by
NP-specific antibody testing with competitive enzyme linked
immuno-sorbent assay (ELISA) and haemagglutinin inhibition
(HI) test using H4 and H5 subtype antigens. The ducks were
randomly assembled into two experimental groups (male and
female ducks were included in each group in approximately equal
numbers) and each group was housed separately in self-contained
isolation units, including: H4 group: twelve ducks which were
inoculated via ocular, nasal and oropharyngeal routes with one
millilitre (10
6 EID50) of the H4N6 strain; H5 group: twelve ducks
inoculated in the same way and the same doses with the H5N2
strain; Control group: eight ducks stayed in quarantine until
challenge. All birds were continuously monitored for clinical
symptoms and blood samples were collected at 1, 2, 4 and 7 weeks
after LPAIV inoculation. Serum samples were tested by ELISA
and HI tests.
Seven weeks after LPAIV inoculation, all 32 birds (including
controls) were housed together in a BSL-3-Ag facility at the FLI.
Oropharyngeal and cloacal swabs were collected from each bird to
exclude active infection with and shedding of H4 or H5 LPAIV.
Subsequently, all birds were challenged with 10
5 TCID50 of
HPAIV H5N1 strain via ocular, nasal and oropharyngeal routes.
The birds were then monitored daily for clinical signs of disease.
Oropharyngeal and cloacal swabs were collected from all birds at
1, 2, 3, 4, 7, 10, 14 and 21 days post challenge (dpc) and tested by
real-time RT-PCR. The experiment was terminated at 24 dpc
when serum samples were collected for serological testing and
tissue samples including brain, lungs, liver and pancreas were
obtained for virological evaluation.
Hypothesis test of differences between groups are carried out by
a Mann-Whitney-U-Test in R.
Real-time reverse transcription-PCR (RT-PCR)
Swab and tissue samples were tested with TaqMan one-step
real-time RT-PCR assays targeting the influenza A virus M gene
[18] and an H5 subtype gene fragment [19] using the SuperScript
III One-step RT-PCR kit with Platinum Taq DNA polymerase
(Invitrogen) on a MX3000P Real-Time PCR System (Stratagene).
In all tests, negative RNA preparation controls, and negative and
positive RT-PCR controls as well as an internal transcription and
amplification control (IC-2) were included [20]. The number of
viral M gene copies or genome equivalent copy numbers (GEC) in
100 ml of the swab samples fluid was determined on basis of
calibration experiments using RNA run-off transcripts of a plasmid
carrying the M gene fragment under control of a T7 promoter
(Figure 1).
Hemagglutination inhibition (HI) assay
The hemagglutination inhibition (HI) assay was performed as
previously described [19] using four hemagglutination units of
inactivated antigen prepared from AIV strains A/mallard/Fo ¨hr
(Germany)/Wv1806-09K/03 (H4N6), A/duck/Potsdam/1402/
86 (H5N2) and A/duck/Vietnam/TG24-01/05 (H5N1).
Competitive ELISA
The serum samples were tested with a competitive ELISA
targeting influenza A nucleoprotein antibodies following the
Figure 1. Regression analysis for the calibration of the genome
equivalent RNA copy numbers (triangles) and the tissue
culture infectious doses 50% endpoints (squares). Log10 dilution
series of quantified RNA run-off transcripts or replication-competent
H5N1 virus (infectivity titrated on MDCK cell culture) were used.
doi:10.1371/journal.pone.0006706.g001
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Competition, ID.VET).
Serum neutralisation test
The serum samples of all ducks have been tested by serum
neutralization test (SNT), to quantify the serologic response, based
on a previously described procedure [21].
Virus titration
The titre of HPAIV in the swab samples was extrapolated from
Ct-values on basis of calibration experiments using different log10
dilution series of A/duck/Vietnam/TG24-01/05 (H5N1) virus.
Infectivity is expressed as TCID50 per 100 ml of the swab sample
fluids (Figure 1).
Immunohistochemistry and pathology
Tissues samples including trachea, lungs, heart, cerebrum,
cerebellum, spinal cord, proventriculus, gizzard, small and large
intestine, liver, pancreas and kidney of two birds from the control
group, which died at 5 and 6 dpc, were collected, formalin fixed
and processed for paraffin embedding according to standard
procedures, and immunohistochemistry for influenza virus A
nucleoprotein (NP) was performed. Briefly, after dewaxing sections
were microwave irradiated for antigen retrieval (265 min, 600 W,
10 mM citrate buffer pH 6.0) and were incubated with a rabbit
anti-NP serum (1:750). A biotinylated goat anti-rabbit IgG1
(Vector, Burlingame, CA, USA) was applied (1:200) as secondary
antibody. By means of the avidin-biotin-peroxidase complex
method, a bright red intracytoplasmatic and nuclear signal was
observed. Positive control tissues of chickens experimentally
infected with HPAI virus (H5N1) and additionally, a control
primary rabbit serum against bovine papillomavirus (BPV 1:2000)
were included.
Results
Status before LPAIV exposure
The cloacal and oropharyngeal swab samples collected from 32
ducks during 8 weeks prior to LPAIV inoculation revealed negative
results by real-time RT-PCR, indicating that the ducks were not
shedding AIV before experimental infection. In addition, ducks were
serologicallynegativetoinfluenzaAantigenstestedbyELISAandHI
tests (with using H4N6, H5N2 and H5N1 antigens), indicating that
the birds were not exposed to AIV before inoculation.
LPAIV infection and status before HPAIV challenge
All birds remained clinically healthy during seven weeks after
inoculation of H4 and H5 LPAIV. The results of serological
evaluation of ducks by ELISA and HI tests using the homologous
antigens at 1, 2, 4 and 7 weeks after inoculation are summarized in
Table 1. Serum samples from the control group were serologically
negative when tested by ELISA, HI and serum neutralization tests.
The cloacal and oropharyngeal swab samples collected from all
ducks before challenge, were negative in real-time RT-PCR
indicating no virus shedding before HPAIV inoculation.
HPAIV challenge infection
Clinical symptoms. Clinical symptoms varied significantly
among members of the three groups. From day two after
inoculation onwards, up to seven ducks in the control group
became severely sick, but only one of the control birds died (6 dpc)
while others recovered slowly. One more duck died at 5 dpc.
Unfortunately due to loss of the wing tag of this bird and also
another bird from the H4 group at the same day, it could not be
unambiguously assigned to either H4 or control groups (see also
footnote 6 in Table 2). Clinical signs included severe weakness, loss
of appetite, mild diarrhea and listlessness. Neurological signs
mainly consisting of neck tremor were evident in one of the control
ducks. Three out of 12 ducks from the H4 group transiently
showed mild clinical symptoms consisting of listlessness and loss of
appetite. In one duck of this group unilaterally a cloudy eye was
evident. No clinical signs were observed in the H5 group.
Respiratory & intestinal viral shedding. The results of the
real-time RT-PCR testing of cloacal and oropharyngeal swab
samples taken on days 1, 2, 3, 4, 7, 10, 14, 21 after challenge are
summarized in Figure 2 and Table 2. Cloacal and oropharyngeal
excretion of HPAIV (H5N1) varied significantly among the three
groups. In general, oropharyngeal excretion was much more
pronounced. In the control group, viral shedding from the
respiratory tract started at 1 dpc and continued with high viral
genome loads for four days (on average 2.5610
5, 1.4610
5,
8.7610
4 and 3.6610
4 GEC per 100 ml of swab fluid for the first
four days which relates to infectivity titres of 5.6610
3, 2.5610
3,
1.4610
3 and 5.1610
2 TCID50 in 100 ml of swab fluid,
respectively; Table 2). During these days also peaks of clinical
signs were observed. Shedding continued in seven and four control
ducks, respectively, until 7 and 10 dpc (Table 2). Two ducks from
the control group continued respiratory viral shedding at low virus
genome loads for two weeks and one duck continued for three
Table 1. The serological status of ducks inoculated by LPAI H4 and H5 viruses and challenged by HPAIV H5N1 as evaluated by
competitive ELISA, HI and serum neutralisation tests.
Group ELISA
1 H4N6 HI
2 H5N2-HI H5N1-HI SN-test
3
B.I.
4 1* 2 4 7
Post
C. B.I. 1 2 4 7 B.I. 1 2 4 7 Post C.
5
Before
C.
Post
C.
H5 0/12 12/12 12/12 7/12 6/12 12/12 ,2 ,2
6 ,2 ,2 ,2 ,25 . 1 60.8 5.860.8 5.760.5 460.4 6.761.1 5.4 9.5
H4 0/12 12/12 12/12 9/12 3/12 12/12 ,22 . 6 62.2 4.361.4 460.9 2.361 ,2 ,2 ,2 ,2 ,2 7.260.9 2 8.4
Control 0/8 0/8 0/8 0/8 0/8 7/7 ,2 ,2 ,2 ,2 ,2 ,2 ,2 ,2 ,2 ,2 8.460.9 ,2 8.7
*The numbers indicate weeks after LPAIV inoculation.
1The ELISA results indicated as the number of positives out of the number of tested birds.
2Hemagglutination inhibition results indicate the geometric mean titre of (log2) serum samples and mean log26standard deviation.
3Carried out against AI virus A/cygnus cygnus/Germany/R65/06 (H5N1) and expressed as geometric mean titre of (log2) serum samples.
4Before LPAIV H4N6 or H5N2 inoculation.
5Post C.=24 days post challenge. Before C.=the day of challenge, before inoculation of HPAIV.
6None of the ducks with mean titre of ,2, showed reactivity higher than 1 log2.
doi:10.1371/journal.pone.0006706.t001
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(Table 2). The ducks of the control group also excreted virus from
the intestinal tract during the first week after infection, but at lower
average genome loads (mean GEC/100 ml at 3 dpi: 8.7610
4 vs.
2.2610
4;p ,0.05) and also for a shorter time compared to
oropharyngeal swabs (Figure 2, Table 2). All cloacal samples were
negative after one week post challenge infection.
Cloacal shedding was not observed in ducks from groups with
previous LPAIV infection. Clear differences were also seen
regarding the oropharyngeal shedding of the H4 and H5 groups,
especially on day 3 and 4 significant differences in tracheal
shedding is observed between all three groups (Figure 2). Whereas
in the H4 group viral genome loads of 7.5610
4, 7.1610
4 and
2.3610
4 GEC/100 ml (equal to 1.4610
3, 1.3610
3 and 3.1610
2
TCID50) were observed during the first three dpc, samples from
only three ducks of the H5 group with loads less than 1.8610
3
GEC/100 ml were found positive (Table 2). The viral genome
loads were higher and lasted for longer periods in oropharyngeal
swabs of the control group than in samples of groups immunized
with heterologous (H4) or homologous (H5) LPAIV respectively
(mean GEC/100 ml 3 at dpi: 8.7610
4 vs. 2.3610
4 vs. 3.0610
2;
p,0.05).
Tissue samples comprising brain, lung, liver and pancreas from
the one control duck which died at 6 dpc were highly positive in
real-time RT-PCR (2.0610
7, 5.1610
4, 4.4610
4 and 1.1610
6
GEC/100 mg, respectively). No viral RNA/infectivity was detect-
ed in the same tissues from any of the ducks surviving until 24 dpc.
Serological findings. Surviving ducks in all three groups
developed high levels of HPAIV H5-specific antibodies post-
challenge according to NP-ELISA, H5-specific HI and serum
neutralization tests (Table 1). Serum neutralization titres against
the challenge virus at 24 dpc ranged around 9 log2 (1:512) in all
three groups with no significant differences among them.
Pathological findings. The control duck, which died at 6 dpc
showed moderate congestion of the liver and edema of the brain. In
histopathology, the cerebrum was severely congested, multifocally
there was neuropil degeneration with mild vacuolation (Figure 3A)
hemorrhage and glial nodules. Ventricles of the cerebrum were filled
with blood, and a mild lymphoplasmacellular meningoencephalitis
with few macrophages was present. Within the lungs there was a
moderate congestion and edema. Besides this, severe heterophilic
infiltrates, predominantly adjacent to parabronchi were observed.
T h eh e a r ta n dt h el i v e rs h o w e dm i l dm u l t i f o c a lp a r e n c h y m a l
degeneration accompanied by lymphoplasma-histiocytic infiltrates.
Influenza virus nucleoprotein was detected by immunohistochemistry
within the brain (neurons and glial cells, Figure 3B), the liver
(hepatocytes), the lung (bronchiolar epithelium and alveolar
macrophages) and the heart (myocardiocytes). One more duck died
at 5 dpc with abovementioned clinical signs, but due to loss of its wing
tag, it could not be unambiguously assigned to either H4 or control
groups (see also footnote 6 in Table 2). Ducks surviving until 24 dpc
did not reveal any gross lesions.
Figure 2. Excretion of HPAIV H5N1 viral RNA via the
respiratory (A) or intestinal (B) tracts as measured by rRT
PCR targeting a M gene fragment in three groups of
experimentally challenged mallards. Average of virus excretion
and 95% confidence intervals are depicted.
doi:10.1371/journal.pone.0006706.g002
Figure 3. Histopathology and immunohistochemistry of brain
from infected ducks. (A) Brain, Cerebrum; Duck at 5 dpc. Congestion
shown by hematoxylin-eosin staining. Bar 100 mm. (B) Brain, Cerebrum;
Duck at 6 dpc. Intense intranuclear and intracytoplasmic AIV antigen
staining within neurons and neuroglia. Immunohistochemistry. ABC
method using anti-NP monoclonal antibody HB65, hematoxylin
counterstain. Bar 100 mm.
doi:10.1371/journal.pone.0006706.g003
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Here we show that pre-existing immunity induced by infection
with homo- or heterosubtypic LPAIV modifies the course of an
experimental challenge infection with HPAIV H5N1 in mallards.
Clinical signs as well as amplitude and tissue tropism of virus
shedding was affected.
Seven (out of eight) control ducks became severely sick. In
contrast, only three ducks (out of 12) with previous H4N6 infection
showed mild clinical symptoms but recovered fast, and no clinical
symptoms were obvious in ducks with previous H5N2 LPAIV
infection. Viral shedding from the respiratory tract was most
pronounced in control ducks. Preferential viral shedding via the
oropharynx has been consistently demonstrated with HPAIV
H5N1 viruses [9,12,22].Two controls ducks even continued viral
shedding at low titres for two more weeks after resolution of
clinical symptoms. Viral shedding in the H4 group was markedly
shortened and at lower titres (3 and 4 dpc). Just a few ducks from
the H5 group were shedding the virus at very low titres compared
to the control group. Cloacal viral shedding was evident only in
ducks of the control group.
Clinical symptoms in ducks of the control group seemed to be
more severe that has previously been reported for experimental
inoculation of naive mallards with HPAIV H5N1 [9,23]. The
observed variability in clinical symptoms and modes of oropha-
ryngeal viral shedding among different studies could be due to
virus strain-specific characteristics [22,24,25]. However, low level
pre-existing AIV-specific immunity could explain the attenuation
effect seen in some birds tested in previous studies.
Long-distance migration is one of the most demanding
physiologic activities in the animal world [26] and although no
overt clinical symptoms have been observed during previous
experimental HPAIV infections of mallards, these birds may not
have been able to engage on long distance migration flights at the
height of viral infection. Previous experimental studies demon-
strated that oropharyngeally excreted HPAIV originated from
lung and air sacs [12], implicating a high replication rate of the
virus and thus a possible functional impairment in organs
important for long-distance flight and migration. From this point
of view it seems more likely to assume that long distance
transposition of HPAIV by migrating Anatidae might rather occur
during the incubation period. This period may last only a few
days. Nevertheless, in this study two control ducks shed virus for
more than seven days after resolving of clinical signs of infection
albeit at lower titers. Therefore, these birds may contribute to local
transmission of the virus. Also, many ducks of the H4 group were
shedding the virus, again at lower titers, in absence of clinical
disease. Spread of virus by such individuals, at least over shorter to
medium distances, can likewise not by excluded. Also, the high
intra-species variability in susceptibility to HPAI (H5N1) viruses
observed in many wild bird species during regional outbreaks in
Europe in 2006 and 2007 may in fact be also explained by
different levels of AIV-specific immunity primed by previous
LPAIV infections.
In summary, the results of our study show that, in captive
mallards, heterosubtypic cross reactive immunity can derogate
clinical symptoms of an HPAIV H5N1 infection, reduce the
amount and duration of viral shedding from the respiratory tract
and prevent viral shedding from the intestinal tract. Homosubtypic
immunity may fully abrogate clinical symptoms and viral shedding
from the intestinal tract, and drastically reduce viral shedding from
the respiratory tract. Therefore, mallards with prior exposure to
homologous LPAI viruses may remain healthy and might be
suitable for long-distance transposition of HPAIV, but probably
only shed very low titers of virus. Mallards with prior exposure to
heterosubtypic LPAI viruses might pose a greater risk for
transmission and spread of HPAIV, because they can shed higher
amounts of virus (but only via the respiratory route) without
developing severe clinical disease. Still, the potential role of
respiratory shedding compared to intestinal shedding in the
efficacy of bird-to-bird transmission of HPAIV in the nature needs
to be clarified.
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